Answers are grounded in this paper and cite their sources.
The finding of excessive catecholamine excretion provides a physiological basis for using catecholamine blocking agents to treat some patients with neuroleptic malignant syndrome.
The authors describe a patient with the neuroleptic malignant syndrome whose excessive catecholamine excretion indicates hyperactivity of the sympathoadrenomedullary component of the autonomic nervous system. Their finding provides a physiological basis for using catecholamine blocking agents to treat some patients with this syndrome.
No takes yet. Share an insight, caveat, or question.
Feibel et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: